TransThera Sciences announces annual shareholder meeting

• Transthera Sciences (Nanjing) will hold its annual general meeting as a virtual meeting on June 18, 2026.
• Shareholders will vote on the 2025 board report, supervisory committee report, audited consolidated financial statements, annual report, profit distribution plan, and uncovered losses.
• Items also include reappointing Ernst & Young as 2026 auditor, setting 2026 pay plans for directors and supervisors, and appointing Feng Weibo as an independent director.
• Special resolutions cover mandates to issue shares, repurchase H shares, extend the issuance mandate by shares repurchased, and cancel the supervisory committee.
• Proposals also include changes to the business scope, amendments to the articles of association, and updates to related appendices.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transthera Sciences (Nanjing) Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260526-12171938), on May 26, 2026, and is solely responsible for the information contained therein.